• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过将胆固醇掺入并转化为粪甾醇,乳酸菌将胆固醇去除。

Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol.

机构信息

School of Industrial Technology, Universiti Sains Malaysia, 11800 USM, Panang, Malaysia.

出版信息

J Dairy Sci. 2010 Apr;93(4):1383-92. doi: 10.3168/jds.2009-2574.

DOI:10.3168/jds.2009-2574
PMID:20338415
Abstract

Fifteen strains of Lactobacillus and Bifidobacterium were screened based on their ability to adhere to hydrocarbons via the determination of cellular hydrophobicity. Lactobacillus acidophilus ATCC 314, L. acidophilus FTCC 0291, Lactobacillus bulgaricus FTCC 0411, L. bulgaricus FTDC 1311, and L. casei ATCC 393 showed greater hydrophobicity and, thus, were selected for examination of cholesterol-removal properties. All selected strains showed changes in cellular fatty acid compositions, especially total fatty acids and saturated and unsaturated fatty acids in the presence of cholesterol compared with those grown in the absence of cholesterol. In addition, we found that cells grown in media containing cholesterol were more resistant to sonication and enzymatic lysis compared with those grown without cholesterol. We further evaluated the location of the incorporated cholesterol via the insertion of fluorescence probes into the cellular membrane. In general, enrichment of cholesterol was found in the regions of the phospholipid tails, upper phospholipids, and polar heads of the cellular membrane phospholipid bilayer. Our results also showed that lactobacilli were able to reduce cholesterol via conversion of cholesterol to coprostanol, aided by the ability of strains to produce cholesterol reductase. Our results provided experimental evidence to strengthen the hypothesis that probiotics could remove cholesterol via the incorporation of cholesterol into the cellular membrane and conversion of cholesterol to coprostanol. The strains studied may be potential health adjunct cultures in fermented dairy products with possible in vivo hypocholesterolemic effects.

摘要

通过测定细胞疏水性,从 15 株乳杆菌和双歧杆菌中筛选出具有附着在碳氢化合物上的能力的菌株。嗜酸乳杆菌 ATCC 314、嗜酸乳杆菌 FTCC 0291、保加利亚乳杆菌 FTCC 0411、保加利亚乳杆菌 FTDC 1311 和干酪乳杆菌 ATCC 393 表现出更高的疏水性,因此被选中用于研究其去除胆固醇的特性。所有选定的菌株的细胞脂肪酸组成都发生了变化,特别是在存在胆固醇的情况下,总脂肪酸以及饱和脂肪酸和不饱和脂肪酸与在不存在胆固醇的情况下相比有所变化。此外,我们发现与在不含胆固醇的培养基中生长的细胞相比,在含有胆固醇的培养基中生长的细胞对超声处理和酶裂解更具抗性。我们进一步通过将荧光探针插入细胞膜来评估掺入的胆固醇的位置。一般来说,胆固醇在细胞膜磷脂双分子层的磷脂尾部、上层磷脂和极性头部区域富集。我们的结果还表明,乳杆菌通过将胆固醇转化为粪甾醇,从而降低胆固醇,这得益于菌株产生胆固醇还原酶的能力。我们的结果提供了实验证据,加强了益生菌可以通过将胆固醇掺入细胞膜并将胆固醇转化为粪甾醇来去除胆固醇的假设。所研究的菌株可能是发酵乳制品中潜在的健康辅助培养物,具有体内降胆固醇的潜在作用。

相似文献

1
Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol.通过将胆固醇掺入并转化为粪甾醇,乳酸菌将胆固醇去除。
J Dairy Sci. 2010 Apr;93(4):1383-92. doi: 10.3168/jds.2009-2574.
2
Acid and bile tolerance and cholesterol removal ability of lactobacilli strains.乳酸菌菌株的耐酸和耐胆汁能力以及胆固醇去除能力。
J Dairy Sci. 2005 Jan;88(1):55-66. doi: 10.3168/jds.S0022-0302(05)72662-X.
3
Incorporation of cholesterol into the cellular membrane of Lactobacillus acidophilus ATCC 43121.胆固醇掺入嗜酸乳杆菌ATCC 43121的细胞膜中。
J Dairy Sci. 1997 Dec;80(12):3107-13. doi: 10.3168/jds.S0022-0302(97)76281-7.
4
Ultrasound treatment enhances cholesterol removal ability of lactobacilli.超声处理增强了乳酸菌去除胆固醇的能力。
Ultrason Sonochem. 2012 May;19(3):632-41. doi: 10.1016/j.ultsonch.2011.08.004. Epub 2011 Aug 25.
5
The effects of Lactobacillus-fermented milk on lipid metabolism in hamsters fed on high-cholesterol diet.乳酸杆菌发酵乳对高胆固醇饮食仓鼠脂质代谢的影响。
Appl Microbiol Biotechnol. 2006 Jun;71(2):238-45. doi: 10.1007/s00253-005-0145-0. Epub 2005 Sep 20.
6
Antioxidant and cholesterol assimilation activities of selected lactobacilli and lactococci cultures.所选乳酸杆菌和乳酸球菌培养物的抗氧化及胆固醇同化活性
J Dairy Res. 2009 Nov;76(4):385-91. doi: 10.1017/S0022029909990094. Epub 2009 Jul 29.
7
Incorporation of cholesterol into the cellular membrane of Bifidobacterium longum.胆固醇掺入长双歧杆菌的细胞膜中。
J Dairy Sci. 1998 Jul;81(7):1818-24. doi: 10.3168/jds.S0022-0302(98)75751-0.
8
Conjugated linoleic acid conversion by dairy bacteria cultured in MRS broth and buffalo milk.在MRS肉汤和水牛奶中培养的乳杆菌对共轭亚油酸的转化
Lett Appl Microbiol. 2007 May;44(5):467-74. doi: 10.1111/j.1472-765X.2007.02135.x.
9
[Progress in the effect of probiotics on cholesterol and its mechanism].[益生菌对胆固醇的影响及其机制研究进展]
Wei Sheng Wu Xue Bao. 2005 Apr;45(2):315-9.
10
Effect of prebiotics on viability and growth characteristics of probiotics in soymilk.益生菌在豆浆中存活和生长特性受益生元的影响。
J Sci Food Agric. 2010 Jan 30;90(2):267-75. doi: 10.1002/jsfa.3808.

引用本文的文献

1
Effect of encapsulation technology and digestion on the hypocholesterolemic activity of K73.包封技术和消化对K73降胆固醇活性的影响。
Front Microbiol. 2025 Aug 29;16:1622211. doi: 10.3389/fmicb.2025.1622211. eCollection 2025.
2
(Sangzhi) Alkaloids Improve Pancreatic β-Cell Function Through Gut Microbial and Intra-Islet 2-Methoxyestradiol Biosynthesis.(桑植)生物碱通过肠道微生物群和胰岛内2-甲氧基雌二醇生物合成改善胰腺β细胞功能。
Biomedicines. 2025 Aug 19;13(8):2013. doi: 10.3390/biomedicines13082013.
3
Probiotic potential of ginseng derived Lacticaseibacillus rhamnosus strains with hypocholesterolemic, antioxidant and antibacterial activities.
具有降胆固醇、抗氧化和抗菌活性的人参源鼠李糖乳杆菌菌株的益生菌潜力。
Sci Rep. 2025 Aug 9;15(1):29222. doi: 10.1038/s41598-025-13364-x.
4
Biodegradation of Cholesterol by YS01 Isolated from the Gut of Healthy Individuals.从健康个体肠道中分离出的YS01对胆固醇的生物降解作用。
Microorganisms. 2025 Jun 22;13(7):1451. doi: 10.3390/microorganisms13071451.
5
Synbiotic Administration of d-Tagatose and ATCC 393 Improves Hyperlipidemia in BALB/c Mice by Modulating Gut Microbiota and Metabolic Parameters.d-塔格糖与ATCC 393的合生元给药通过调节肠道微生物群和代谢参数改善BALB/c小鼠的高脂血症。
Food Sci Nutr. 2025 Jul 10;13(7):e70597. doi: 10.1002/fsn3.70597. eCollection 2025 Jul.
6
The gut-heart axis: unveiling the roles of gut microbiota in cardiovascular diseases.肠-心轴:揭示肠道微生物群在心血管疾病中的作用
Front Cardiovasc Med. 2025 May 26;12:1572948. doi: 10.3389/fcvm.2025.1572948. eCollection 2025.
7
Impact of Probiotics Administration on the VEGF, Adiponectin, and Glycolipid Metabolism, in Prediabetic Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.益生菌给药对糖尿病前期患者血管内皮生长因子、脂联素及糖脂代谢的影响:一项随机、双盲、安慰剂对照临床试验
Food Sci Nutr. 2025 May 1;13(5):e70146. doi: 10.1002/fsn3.70146. eCollection 2025 May.
8
Evaluating the safety and efficacy of TISTR 2593 as a therapeutic probiotic for obesity prevention.评估TISTR 2593作为预防肥胖的治疗性益生菌的安全性和有效性。
Front Microbiol. 2025 Apr 2;16:1501395. doi: 10.3389/fmicb.2025.1501395. eCollection 2025.
9
Disturbances in the gut microbiota potentially associated with metabolic syndrome among patients living with HIV-1 and on antiretroviral therapy at Bafoussam Regional Hospital, Cameroon.喀麦隆巴富萨姆地区医院接受抗逆转录病毒治疗的HIV-1感染者中,肠道微生物群紊乱可能与代谢综合征有关。
Diabetol Metab Syndr. 2025 Mar 15;17(1):86. doi: 10.1186/s13098-025-01653-4.
10
Effects of a multi-strain probiotic on productive traits, antioxidant defence, caecal microbiota and short‑chain fatty acid profile, and intestinal histomorphology in rabbits.多菌株益生菌对家兔生产性能、抗氧化防御、盲肠微生物群和短链脂肪酸谱以及肠道组织形态学的影响
Anim Biosci. 2025 Jun;38(6):1247-1258. doi: 10.5713/ab.24.0716. Epub 2025 Jan 24.